Main Therapeutic Uses

Visceralgine is primarily utilized for the symptomatic relief of pain associated with functional disorders of the gastrointestinal and biliary tracts. As an antispasmodic agent, it works by relaxing the smooth muscles found in internal organs, which helps to alleviate cramping and discomfort.

Gastrointestinal Conditions

The medication is frequently used to manage spasms of the digestive system. This includes relief from:

• Abdominal pain related to bowel movements.
• Intestinal cramping and discomfort.
• Spasms associated with functional digestive disturbances.

Biliary and Urinary Tract Applications

Beyond the digestive tract, Visceralgine is also applied to address spasmodic pain in other systems where smooth muscle contraction occurs:

• Biliary Colic: It helps manage the intense pain caused by spasms in the bile ducts.
• Urinary Tract: It may be used to relieve pain resulting from spasms in the urinary system, such as renal colic.

Gynecological Support

In gynecology, the medication is used to treat spasmodic pain related to the female reproductive system, particularly for the relief of painful menstruation (dysmenorrhea).

Benefits and Mechanism

The primary benefit of Visceralgine is its ability to target the source of visceral pain—muscle spasms—without significantly affecting normal physiological functions. By reducing the frequency and intensity of these contractions, it allows for:

• Reduction in localized cramping.
• Improved comfort during acute episodes of pain.
• Management of chronic functional disorders characterized by smooth muscle hyperactivity.

The eligibility for Visceralgine is strictly defined by regulatory documents based on pre-existing conditions and known physiological states, primarily to prevent adverse outcomes.

Populations That Must Not Use Visceralgine (Contraindications)

Visceralgine is formally contraindicated in patients with the following conditions, depending on the specific active ingredient (phloroglucinol or tiemonium methylsulphate) of the formulation:

• Known Hypersensitivity to the active substance or any other component in the medicine (excipients).
• Risk of Acute Glaucoma (specifically angle closure glaucoma).
• Urethroprostatic Disorder that involves a risk of urinary retention (difficulty to urinate).
• Hereditary Disorders such as Phenylketonuria (if the formulation contains aspartame) or certain sugar intolerances like galactose intolerance (if the formulation contains lactose).
• Other Conditions listed in some national labels, including paralytic ileus, pyloric stenosis, tachycardia, and myocardial infarction.

Use Restrictions and Special Considerations

Official labeling defines limitations for use in the following populations:

Population	Eligibility Status	Basis in Regulatory Documents
Pregnancy	Use only if clearly necessary.	Lack of sufficient data; use must be carefully assessed.
Breast-feeding	Avoid or not recommended.	Absence of sufficient safety data for the infant.
Children	Efficacy and safety may not be established.	Age-related safety data is limited for some formulations.
Prostate Disorders	Caution must be exercised.	Increased risk of complications, such as urine retention.

Eligibility is confirmed only when the patient is free from all documented contraindications and restrictions can be managed by a healthcare provider.

Visceralgine Interactions with other medicines and products

Visceralgine (Tiemonium methylsulphate) possesses anticholinergic properties, which means it can interact with other medications that share similar effects. Inform your healthcare provider of all prescription drugs, over-the-counter products, and herbal supplements you are currently taking to prevent potential drug interactions and ensure treatment safety.

---

Medications that Increase Risk of Side Effects

Concurrent use of Visceralgine with certain medications can increase the risk or severity of anticholinergic side effects such as dry mouth, blurred vision, constipation, or a rapid heart rate (tachycardia). These include:

• Other Anticholinergic Agents: Drugs like atropine or hyoscyamine, as well as certain medications for Parkinson’s disease.
• Tricyclic Antidepressants (TCAs): Such as amitriptyline or nortriptyline.
• Antihistamines: Especially first-generation agents like diphenhydramine, which also have anticholinergic activity.
• Monoamine Oxidase Inhibitors (MAOIs): Combining with these may lead to heightened anticholinergic effects.

---

Reduced Efficacy of Visceralgine

Drugs that affect gastrointestinal motility may reduce the efficacy of Visceralgine due to opposing pharmacological actions. Examples include agents like metoclopramide.

---

Other Notable Interactions

The risk or severity of tachycardia may be increased when Visceralgine is combined with certain bronchodilators, sympathomimetics, or other drugs that can affect heart rate. Always consult a physician before initiating any new medication while taking Visceralgine.

Visceralgine (Tiemonium Iodide/Methylsulfate) modulates key signaling pathways that regulate smooth muscle contraction, ultimately promoting the relaxation of smooth muscle fibers in visceral organs.

---

Antagonism of Muscarinic Receptors

This core mechanism involves the drug acting as a competitive antagonist of acetylcholine at muscarinic receptors expressed on the smooth muscle cells of the gastrointestinal and urinary tracts. By engaging these receptors, Visceralgine limits the efferent neurological signals that initiate contraction. This action results in the limitation of parasympathetic nerve stimulation, which establishes a reduced state of basal muscle tone within the targeted visceral tissues.

---

Modulation of Intracellular Ion Dynamics

Visceralgine also engages a secondary mechanism influencing the final steps of the contractile process, which are dependent on calcium ions. The drug strengthens the association of calcium with membrane phospholipids and proteins, which functions to inhibit the activity of intracellular contractile proteins within the visceral cells. This cascade modifies the molecular steps leading to smooth muscle fiber shortening, serving as an additional pathway to induce muscle relaxation by reducing the rate and amplitude of physiological response within the affected tissues.

Official Administration Instructions (Tiemonium Methylsulphate)

Visceralgine is administered via multiple routes based on the prescribed dosage form:

• Oral Administration: For tablets (e.g., 50 mg) and syrup (e.g., 10 mg/5 ml), the medicine is taken by mouth.
• Injectable Administration: The injection form (5 mg/2 ml ampoule) is administered by a healthcare professional through the Intravenous (IV) or Intramuscular (IM) route.
• Rectal Administration: The suppository form (20 mg) is inserted rectally.

Labeled Dosing and Frequency

Standard dosage and frequency are categorized as follows:

Population	Form & Route	Standard Dosing Regimen	Frequency
Adults	Tablet (Oral)	100 -300 mg (e.g., 2 -6 tablets) daily	In divided doses
Adults	Syrup (Oral)	15 -45 ml or 3 -9 teaspoonfuls daily	In divided doses
Children	Syrup (Oral)	3 ml/ kg or 6 mg/ kg body weight daily	In divided doses
All Ages	Injection (IV/IM)	5 mg (one ampoule)	3 times daily
All Ages	Suppository (Rectal)	20 mg (one suppository)	2 -3 times daily

Special Administration Rules

• Procedural Technique: When administered via the intravenous route, the injection must be given slowly.
• Age-Specific Use: The safety and effectiveness of this medicine in paediatric patients have not been formally established. Efficacy and safety are maintained with increasing age in the geriatric population.

The administration of the medication follows specific methods, amounts, and schedules across its different forms.

Visceralgine, whose active ingredient is Tiemonium Methylsulphate, is an antispasmodic agent primarily used for the symptomatic relief of pain associated with functional disorders of the digestive, biliary, urological, and gynecological systems. As an anticholinergic compound, its mechanism of action involves acting as a competitive antagonist of acetylcholine and histamine receptors. This action leads to the relaxation of smooth muscle in the visceral organs, which helps to alleviate the painful spasms and cramps characteristic of conditions like Irritable Bowel Syndrome (IBS) and renal or biliary colic.

Recent clinical assessments and authoritative reviews have consistently reaffirmed its role as a first-line treatment for acute visceral spasms. While it is classified as a symptomatic therapy for functional bowel disorders, studies highlight its efficacy in reducing the intensity and frequency of abdominal pain. Its use is based on its direct effect on inhibiting the contractile proteins within the visceral muscle cells, which is responsible for the pain.

Safety Profile and Considerations

The safety and effectiveness of Visceralgine have been maintained in the geriatric population, though data on its use in pediatric patients remain limited. Clinical research emphasizes the need for caution in patients with pre-existing conditions that could be exacerbated by anticholinergic effects. These include disorders such as angle-closure glaucoma and urethroprostatic disorders that carry a risk of urinary retention.

Contraindication Category	Examples of Conditions
Ocular	Angle-closure Glaucoma
Uroprostatic	Conditions involving risk of Urinary Retention

Reported adverse effects are typically related to its anticholinergic nature, with common issues being dry mouth, constipation, and blurred vision. The potential for systemic effects like hypotension (low blood pressure) and tachycardia (fast heart rate) is also noted, necessitating careful administration, especially in injection form. It is generally advised to avoid co-administration with other anticholinergic drugs, as this may potentiate side effects.

Common questions about Visceralgine (FAQ)

Q: What kind of pain is Visceralgine approved to treat?

Official regulatory documents describe the medicine's approved uses for pain related to visceral muscle spasms. This refers to the involuntary tightening of smooth muscles within organs like the intestine, biliary system, urinary bladder, and uterus.

Q: Is Visceralgine used for stomach cramps or just general abdominal pain?

The medicine is classified as an antispasmodic for pain caused by functional disorders and spasms of the digestive tract and biliary system. This scope of action includes symptoms often experienced as stomach cramps.

Q: How quickly is Visceralgine expected to start working?

Although the actual time it takes to feel relief can vary between individuals, available regulatory-related information suggests that the onset of action typically occurs within 30 to 60 minutes after taking the medicine by mouth.

Q: How long does the effect of Visceralgine typically last?

Information found in official product documentation indicates that the duration of the medicine’s effect generally lasts for several hours.

Q: What are the most commonly reported side effects of Visceralgine?

According to official regulatory information on adverse reactions, some commonly reported side effects include dry mouth, blurred vision, constipation, and dizziness. The full extent of possible side effects varies by individual.

Q: Is a dry mouth a common side effect when using Visceralgine?

Yes, dry mouth is a commonly reported side effect. This is related to the medicine’s anticholinergic properties, which can affect the normal regulation of saliva secretion.

Q: Are there any specific medical conditions where Visceralgine should not be used?

Official prescribing information indicates the medicine is contraindicated (should not be used) in patients with specific conditions. This includes angle-closure glaucoma and difficulties in urination related to prostate or bladder disorders.

Q: Can older adults use Visceralgine?

Regulatory documents indicate that the efficacy and safety profile of the medicine are generally maintained with increasing age.

Q: Is there any information about using Visceralgine during pregnancy or breastfeeding?

Use during pregnancy and lactation is generally not recommended unless a healthcare provider determines that the potential benefit outweighs the possible risks. Official information urges caution in these situations.

Q: Does Visceralgine interact with alcohol?

Regulatory-related information indicates that alcohol use is typically advised to be avoided during treatment. This caution is issued because alcohol may potentially increase the risk of side effects like dizziness.

Q: Do other over-the-counter medicines interact with Visceralgine?

Yes, interactions are possible. The effects of Visceralgine may be enhanced when taken with other medicines that have anticholinergic properties, which can include some over-the-counter antihistamines.

Q: Is it possible for Visceralgine to cause drowsiness or affect driving?

The official warnings for the medicine note that it may cause visual disturbances and dizziness. Official warnings state that these effects may impair a person's ability to drive or operate machinery.

Q: What does official research evidence suggest about Visceralgine's effectiveness?

Research evidence cited in regulatory documents supports its primary function as an antispasmodic agent. Studies have examined its effectiveness for managing pain associated with the visceral muscle spasms it is approved to treat.

Q: Can Visceralgine cause constipation or diarrhea?

Constipation is listed as a potential side effect in regulatory documents, which is consistent with its smooth muscle relaxing action. Diarrhea is not commonly specified as an adverse reaction in the same context.

Q: Are there any known severe or rare side effects associated with Visceralgine?

Yes, regulatory documents describe the potential for severe or rare effects, particularly when administered as an injection. These include a risk of hypotension (low blood pressure) and tachycardia (increased heart rate).

Q: Can children or teenagers use Visceralgine?

Official regulatory documents generally state that the safety and effectiveness of the medicine in pediatric patients (children and adolescents) have not been established.

Q: Does Visceralgine affect blood pressure?

There is a documented risk of hypotension, or low blood pressure, associated with its use. This risk is specifically noted to be higher when the medicine is administered in the injectable form.

Q: Are there warnings about using Visceralgine if you have kidney problems?

Caution should be exercised when treating patients with serious renal insufficiency, which refers to severe kidney problems. This condition requires the oversight of a healthcare provider.

Q: Are there warnings about using Visceralgine if you have liver problems?

Caution should be exercised when treating patients with serious hepatic insufficiency, which refers to severe liver problems. This condition requires the oversight of a healthcare provider.

Q: What is the active ingredient in Visceralgine?

According to the official composition section, the active ingredient that provides the therapeutic effect in Visceralgine is Tiemonium Methylsulphate.

Q: Why is it important to check the full list of ingredients in Visceralgine?

Official drug documents often advise checking the full ingredient list to ensure there is no known hypersensitivity or allergy to the active substance or any of the non-active ingredients (excipients). Some formulations may contain ingredients like anhydrous lactose.

Q: Does Visceralgine interact with medications for depression or anxiety?

Interactions are noted with some classes of medicines used for mental health conditions, such as tricyclic antidepressants and Monoamine Oxidase Inhibitors (MAOIs). These combinations may potentially enhance the effects of Visceralgine.

Q: Can taking Visceralgine cause blurred vision?

Yes, blurred vision is listed as a potential side effect in official information. This effect is related to the medicine's pharmacological properties that can interfere with eye focus.

Q: Is it normal for the pain to return quickly after the effects of Visceralgine wear off?

Since the effect of the medicine is generally described as lasting for several hours, it is an expected part of the treatment cycle for symptoms to begin returning as the concentration of the active ingredient decreases in the body.

Q: Does Visceralgine help with pain that is not related to the digestive system?

Yes, the officially approved indications include pain related to spasms of the uterus and the urinary bladder. This means its use is not limited exclusively to the digestive tract.

Q: What is the main difference between Visceralgine and generic painkillers like paracetamol?

Official documents classify Visceralgine as an antispasmodic agent. Its primary action is to relax specific smooth muscles, which is a different mechanism from how generic painkillers (analgesics) typically work to address pain.

Q: Is Visceralgine classified as a pain reliever or an antispasmodic?

It is officially classified as an antispasmodic agent. While it relieves pain, it does so indirectly by treating the underlying spasm of the smooth muscle.

Q: Can Visceralgine be taken on an empty stomach?

While specific requirements vary, regulatory-related information sometimes advises taking the oral medicine with water. This is generally suggested to potentially enhance gastrointestinal tolerance.

Q: Is Visceralgine a treatment for a long-term condition or only for short-term pain?

The medicine is generally indicated for the symptomatic treatment of pain related to functional disorders. This typically implies use for short-term symptomatic relief rather than as a cure for a chronic or long-term disease.

Q: Is Visceralgine addictive or habit-forming?

Regulatory documentation regarding the medicine's safety and abuse potential does not describe Visceralgine as being addictive or habit-forming.

Q: Why does the packaging say to use Visceralgine with caution if you have glaucoma?

The medicine is strictly contraindicated in patients diagnosed with angle-closure glaucoma. This is because its mechanism of action could potentially worsen that specific eye condition.

Q: What types of clinical trials have been conducted on Visceralgine?

The clinical studies summarized in official documentation have focused on evaluating the medicine's efficacy as an antispasmodic agent for visceral pain and for use in specific combinations or conditions related to its indication.

Q: How does Visceralgine affect muscle spasms specifically?

Official regulatory materials describe its mechanism of action as working to inhibit the intracellular contractile protein of visceral cells. This action directly leads to the relaxation and inhibition of the visceral spasms.

Q: Is Visceralgine a steroid?

No, Visceralgine is not a steroid. It is officially classified as an antispasmodic agent and a muscarinic acetylcholine receptor antagonist.

Q: What is the maximum duration of time Visceralgine is recommended for use?

Since the medicine is primarily intended for the symptomatic relief of functional disorders, its use is typically limited to the period when symptoms are present, as determined and directed by a healthcare provider.

Q: Can Visceralgine be safely taken with supplements like vitamins or herbal products?

Official regulatory information advises against using the medicine with other pharmacological products without consulting a healthcare provider to avoid possible drug interactions. It is important to inform a healthcare provider about the use of any supplements or herbal products.

Q: What is the intended therapeutic class of Visceralgine?

The medicine is officially classified within the therapeutic class of antispasmodic agents and anticholinergics.

Q: What information is available regarding the long-term safety of Visceralgine?

Safety data is provided for the established and generally limited period of use consistent with its symptomatic indication. Long-term use for chronic conditions is not the primary focus of the regulatory indication.

Q: What makes Visceralgine a suitable option for visceral pain?

The medicine's suitability is based on its classification as an antispasmodic agent that specifically targets and relaxes the smooth muscles of the viscera (internal organs), which is the source of visceral pain.

Q: Does Visceralgine need to be stored in a special way?

Regulatory information recommends that the medicine be kept in a cool, dry place, protected from direct light and heat, and generally not stored above a temperature of 30 C.

How to Store and Dispose of Visceralgine?

The official regulatory instructions specify strict conditions for storing Tiemonium Methylsulphate (Visceralgine). The medication must be stored at temperatures below 30 C (or 25 C for some forms) in a dry place.

Storage Requirements

Condition	Requirement
Temperature	Store below 30 C/ 25 C.
Protection	Must be Protected from light and moisture.
Handling	Keep out of children's reach; container must be tightly closed.

Disposal

The disposal of Visceralgine is regulated to protect the environment. Unused or expired medication and its container must be disposed of at an appropriate treatment and disposal facility in accordance with applicable laws. It is strictly required to Avoid discharge into drains or water courses.